All Relations between nps and nasal

Publication Sentence Publish Date Extraction Date Species
A J Gadenstaetter, C D Mayer, L D Landegge. Nasopharyngeal versus nasal swabs for detection of SARS-CoV-2: a systematic review. Rhinology. vol 59. issue 5. 2021-10-26. PMID:34666340. publications investigating nps and at least one other form of nasal specimen collection in combination with rt-pcr for viral detection in the context of covid-19 were assessed. 2021-10-26 2023-08-13 Not clear
Sung-Woo Cho, Dong-Young Kim, Sungmi Choi, Sungho Won, Hye-Ryun Kang, Hana Y. Microbiome profiling of uncinate tissue and nasal polyps in patients with chronic rhinosinusitis using swab and tissue biopsy. PloS one. vol 16. issue 4. 2021-09-17. PMID:33831071. chronic rhinosinusitis (crs) is characterized according to the presence or absence of nasal polyps (nps) and displays nasal microbiota dysbiosis. 2021-09-17 2023-08-13 Not clear
b' Aleksandar Peri\\xc4\\x87, Marko Stoiljkov, Danijela \\xc4\\x90oki\\xc4\\x87, Biserka Vukomanovi\\xc4\\x87 \\xc4\\x90ur\\xc4\\x91evi\\xc4\\x8. Epithelial Squamous Metaplasia and Dysplasia in Inflammatory Nasal Polyps: An Observational Study. Ear, nose, & throat journal. vol 100. issue 2. 2021-09-02. PMID:31309847.' the presence of squamous metaplasia and dysplasia on the mucosal surface of nasal polyps (nps) represents different manifestations of epithelial atypia. 2021-09-02 2023-08-13 Not clear
Ting Zhang, Yong Zhou, Bo You, Yiwen You, Yongbing Yan, Jie Zhang, Yinyin Pei, Wei Zhang, Jing Che. miR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition by Targeting CDK6 in Nasal Polyps. American journal of rhinology & allergy. vol 35. issue 2. 2021-08-18. PMID:32623901. although aberrant expression of mirnas and occurrence of emt were previously reported in nasal polyps (nps), the role of mir-30a-5p in emt of nps is still remains unclear. 2021-08-18 2023-08-13 human
Mengjie Sun, Di Qin, Pengsheng Fan, Xiguang Chen, Ya Li. Chitosan-centered nanosystems as sustained therapeutics for allergic rhinitis intervention: Inhibition of histamine-induced cascades. Journal of controlled release : official journal of the Controlled Release Society. vol 335. 2021-08-11. PMID:34087247. in this regard, kt incorporated and ctz decorated hydroxybutyl chitosan nanoparticles (k ⊂ ch nps) were fabricated as nasal adaptive sequential release dual drug system for long-term ar therapy. 2021-08-11 2023-08-13 Not clear
Ahmet Oguzhan Bicakci, Pei-Ling Tsai, Evelyn Kahl, Dana Mayer, Markus Fend. Dissociative Effects of Neuropeptide S Receptor Deficiency and Nasal Neuropeptide S Administration on T-Maze Discrimination and Reversal Learning. Pharmaceuticals (Basel, Switzerland). vol 14. issue 7. 2021-08-09. PMID:34358069. in the second experiment, c57bl/6j mice were tested in the t-maze after nasal administration of nps. 2021-08-09 2023-08-13 mouse
Ahmet Oguzhan Bicakci, Pei-Ling Tsai, Evelyn Kahl, Dana Mayer, Markus Fend. Dissociative Effects of Neuropeptide S Receptor Deficiency and Nasal Neuropeptide S Administration on T-Maze Discrimination and Reversal Learning. Pharmaceuticals (Basel, Switzerland). vol 14. issue 7. 2021-08-09. PMID:34358069. finally, the effect of nasal nps on locomotor activity was evaluated. 2021-08-09 2023-08-13 mouse
Ahmet Oguzhan Bicakci, Pei-Ling Tsai, Evelyn Kahl, Dana Mayer, Markus Fend. Dissociative Effects of Neuropeptide S Receptor Deficiency and Nasal Neuropeptide S Administration on T-Maze Discrimination and Reversal Learning. Pharmaceuticals (Basel, Switzerland). vol 14. issue 7. 2021-08-09. PMID:34358069. nasal nps administration facilitated reversal learning and supported an allocentric learning strategy without affecting acquisition of the task or locomotor activity. 2021-08-09 2023-08-13 mouse
Ahmet Oguzhan Bicakci, Pei-Ling Tsai, Evelyn Kahl, Dana Mayer, Markus Fend. Dissociative Effects of Neuropeptide S Receptor Deficiency and Nasal Neuropeptide S Administration on T-Maze Discrimination and Reversal Learning. Pharmaceuticals (Basel, Switzerland). vol 14. issue 7. 2021-08-09. PMID:34358069. however, npsr deficiency only improved discrimination learning, while nasal nps administration only improved reversal learning, i.e., cognitive flexibility. 2021-08-09 2023-08-13 mouse
Zhi-Chao Wang, Yin Yao, Cai-Ling Chen, Cui-Lian Guo, Hong-Xia Ding, Jia Song, Zhe-Zheng Wang, Nan Wang, Xue-Li Li, Bo Liao, Yang Yang, Di Yu, Zheng Li. Extrafollicular PD-1 The Journal of allergy and clinical immunology. 2021-07-17. PMID:34224786. extrafollicular pd-1 local immunoglobulin hyperproduction is observed in nasal polyps (nps) with and without ectopic lymphoid tissues (elts). 2021-07-17 2023-08-13 Not clear
Siyuan Ma, Mu Xian, Yang Wang, Chengshuo Wang, Luo Zhan. Budesonide repairs decreased barrier integrity of eosinophilic nasal polyp epithelial cells caused by PM Clinical and translational allergy. vol 11. issue 5. 2021-07-16. PMID:34262692. budesonide repairs decreased barrier integrity of eosinophilic nasal polyp epithelial cells caused by pm eosinophilic chronic rhinitis with nasal polyps (eos-crswnp) is a subtype of nasal polyps (nps) characterized by severe type-2 inflammation and defective epithelial barrier function. 2021-07-16 2023-08-13 Not clear
Luis F González, Eric Acuña, Gabriel Arellano, Paola Morales, Paula Sotomayor, Felipe Oyarzun-Ampuero, Rodrigo Nave. Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy. Journal of controlled release : official journal of the Controlled Release Society. vol 331. 2021-07-07. PMID:33220325. biodistribution analysis showed an early and high fluorescence in the brain after nasal administration of fluorescent probe-loaded nps. 2021-07-07 2023-08-13 mouse
Guangfu Xu, Silong Chen, Yuchun Dong, Li Xia. Th17/1-Biased Inflammatory Environment Involved in the Response of Epithelial Cells to Antigen Stimuli in Nasal Polyps. Journal of immunology research. vol 2021. 2021-07-06. PMID:34222494. several studies showed that il-17a was significantly increased in nasal polyps (nps). 2021-07-06 2023-08-13 Not clear
Homa Boroumand, Fereshteh Badie, Samaneh Mazaheri, Zeynab Sadat Seyedi, Javid Sadri Nahand, Majid Nejati, Hossein Bannazadeh Baghi, Mohammad Abbasi-Kolli, Bita Badehnoosh, Maryam Ghandali, Michael R Hamblin, Hamed Mirzae. Chitosan-Based Nanoparticles Against Viral Infections. Frontiers in cellular and infection microbiology. vol 11. 2021-07-05. PMID:33816349. chitosan nps have been used in drug delivery by the oral, ocular, pulmonary, nasal, mucosal, buccal, or vaginal routes. 2021-07-05 2023-08-13 Not clear
Feng Wang, Yang Yang, Haihong Che. Alteration of Histopathology in Recurrent Nasal Polyps. ORL; journal for oto-rhino-laryngology and its related specialties. 2021-07-01. PMID:34198296. the objective of this study was to analyze the histopathologic changes in recurrent nasal polyps (nps) in terms of tissue inflammatory cells infiltration and mucosal remodeling. 2021-07-01 2023-08-13 Not clear
Zhe-Zheng Wang, Jia Song, Hai Wang, Jing-Xian Li, Qiao Xiao, Ze Yu, Jin-Xin Liu, Zheng Li. B Cell-Activating Factor Promotes B Cell Survival in Ectopic Lymphoid Tissues in Nasal Polyps. Frontiers in immunology. vol 11. 2021-06-24. PMID:33552090. ectopic lymphoid tissues (elts) characterized by b cell aggregation contribute to the local immunoglobulin production in nasal polyps (nps). 2021-06-24 2023-08-13 Not clear
Nao Sano, Shu Kikuta, Kenji Kondo, Tatsuya Yamasob. High CT values relative to the brainstem differentiate inverted papillomas from nasal polyps. Auris, nasus, larynx. vol 48. issue 5. 2021-06-21. PMID:33810925. a diagnostic indicator for the differentiation of inverted papillomas (ips) from inflammatory nasal polyps (nps) has not been established. 2021-06-21 2023-08-13 Not clear
Aikaterini-Theodora Chatzitaki, Sandra Jesus, Christina Karavasili, Dimitrios Andreadis, Dimitrios G Fatouros, Olga Borge. Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety. International journal of pharmaceutics. vol 589. 2021-06-17. PMID:32818538. therefore, the aim of the present study was the development of plga and plga/chitosan (chit) nanoparticles (nps) with mucoadhesive properties, able to encapsulate ropinirole hydrochloride (rh), an anti-parkinsonian dopaminergic agonist, and suitable to promote rh delivery across the nasal mucosa. 2021-06-17 2023-08-13 Not clear
Aikaterini-Theodora Chatzitaki, Sandra Jesus, Christina Karavasili, Dimitrios Andreadis, Dimitrios G Fatouros, Olga Borge. Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety. International journal of pharmaceutics. vol 589. 2021-06-17. PMID:32818538. rh loaded plga/chit nps showed a complete release of the drug in simulated nasal electrolyte solution (snes) over the period of 24 h and increased the permeation of rh through sheep nasal mucosa by 3.22-fold in comparison to plga nps. 2021-06-17 2023-08-13 Not clear
Samira Sadeghi, Wai Kit Lee, Shik Nie Kong, Annanya Shetty, Chester Lee Dru. Oral administration of protein nanoparticles: An emerging route to disease treatment. Pharmacological research. vol 158. 2021-06-04. PMID:32097749. protein nps are currently being employed widely in pharmaceuticals development with applications in nasal, pulmonary, intravenous, ocular and oral delivery. 2021-06-04 2023-08-13 Not clear